02.14.24 -- Mapping The Biosimilar Regulatory Landscape In The Middle East

Explore the potential of mAbs in treating diverse conditions, from cancer to infectious diseases, and learn about their transformation from scientific breakthroughs to life-changing therapies.

Discover how to harness the power of data you generate through a digital data backbone, which allows you to transform the way you capture, analyze, report, and leverage data in upstream development.

Pharmaceutical continuous manufacturing (PCM) offers a number of advantages. Review the key drivers for PCM and the hurdles that stand in the way of industrywide adoption.

Once a company has demonstrated proof of concept, it is critical to consider process elements such as scalability, sourcing raw materials, and GMP adherence.

Explore the latest trends in cell culture technology, tools and enablers for scale-up, strategies to accelerate cell line development, media development, raw material characterization, and more.

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of everyday manufacturing operational excellence.

Discover how high throughput (HTP) screening can utilize membrane chromatography at comparable consumables costs to traditional resins without compromising CQAs for prescribed therapeutics.

Explore the three phases of sterile injectable project tech transfer, including how to bridge information gaps and facilitate successful regulatory filing at this fundamental stage of drug development.

Identifying variations in the expected nutrient profile before its use may prevent undesirable culture outcomes such as poor growth and low productivity.

Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.

Recognizing what it takes to complete technology transfers effectively and efficiently is crucial to selecting the best partner for your project and product needs.

Whether you are running analytical workflows for diagnostics, therapeutics, or vaccines, by applying process optimization throughout the assay workflow, you can improve overall assay performance.

Improve your cleaning and subsequent sterilization process for your bioreactors, ensuring a thorough cleaning, better reproducibility, and reduced labor.

Finding a manufacturing partner with the capabilities and capacity to offer truly end-to-end development and scale-up can mean the difference between successful commercialization and the end of the road.